Liver cancer treatment showdown: which triple therapy causes less damage?
NCT ID NCT07277192
Summary
This study compared two different triple-therapy combinations for treating intermediate-to-advanced liver cancer in 562 patients. Researchers wanted to see which approach caused less liver injury while controlling the cancer. They compared a treatment called HAIC against another called TACE, both combined with immunotherapy and targeted drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATECELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China
Conditions
Explore the condition pages connected to this study.